# NeuroXVocal: Detection and Explanation of Alzheimer's Disease through Non-invasive Analysis of Picture-prompted Speech

Article · Nikolaos Ntampakis, Konstantinos Diamantaras, Ioanna Chouvarda, Magda Tsolaki, Vasileios Argyriou, Panagiotis Sarigianndis

- Archive id: arxiv:2502.10108
- Published: 2025-02-14
- Venue: Medical Image Computing and Computer Assisted Intervention - MICCAI 2025. Lecture Notes in Computer Science, vol 15973. Springer, Cham (2025)
- DOI: https://doi.org/10.1007/978-3-032-05185-1_40
- arXiv: https://arxiv.org/abs/2502.10108
- Citations: 3
- Source URL: https://arxiv.org/abs/2502.10108
- PDF: https://arxiv.org/pdf/2502.10108
- Provenance: arxiv

## Abstract

The early diagnosis of Alzheimer's Disease (AD) through non invasive methods remains a significant healthcare challenge. We present NeuroXVocal, a novel dual-component system that not only classifies but also explains potential AD cases through speech analysis. The classification component (Neuro) processes three distinct data streams: acoustic features capturing speech patterns and voice characteristics, textual features extracted from speech transcriptions, and precomputed embeddings representing linguistic patterns. These streams are fused through a custom transformer-based architecture that enables robust cross-modal interactions. The explainability component (XVocal) implements a Retrieval-Augmented Generation (RAG) approach, leveraging Large Language Models combined with a domain-specific knowledge base of AD research literature. This architecture enables XVocal to retrieve relevant clinical studies and research findings to generate evidence-based context-sensitive explanations of the acoustic and linguistic markers identified in patient speech. Using the IS2021 ADReSSo Challenge benchmark dataset, our system achieved state-of-the-art performance with 95.77% accuracy in AD classification, significantly outperforming previous approaches. The explainability component was qualitatively evaluated using a structured questionnaire completed by medical professionals, validating its clinical relevance. NeuroXVocal's unique combination of high-accuracy classification and interpretable, literature-grounded explanations demonstrates its potential as a practical tool for supporting clinical AD diagnosis.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Alzheimer's, Parkinson's & Neurodegeneration](https://space-kitty.com/topics/neurodegeneration)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.